Literature DB >> 7798557

The phenotype of human eosinophils, basophils, and mast cells.

P Valent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7798557     DOI： 10.1016/0091-6749(94)90329-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  13 in total

1.  Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.

Authors:  A Orfao; L Escribano; J Villarrubia; J L Velasco; C Cerveró; J Ciudad; J L Navarro; J F San Miguel
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; André Rodriguez-Pozo; Quentin Jouhault; Hadjer Abdelhouahab; Nathalie Dereuddre-Bosquet; Vanessa Contreras; Frédéric Martinon; Antonio Cosma; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  NPJ Vaccines       Date:  2020-03-19       Impact factor: 7.344

Review 3.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

4.  Acute basophilic leukemia lacking basophil-specific antigens: the importance of cytokine receptor expression in differential diagnosis.

Authors:  Akihiko Yokohama; Norifumi Tsukamoto; Nahoko Hatsumi; Miwa Suto; Tohru Akiba; Hideki Uchiumi; Tadashi Maehara; Takafumi Matsushima; Masamitsu Karasawa; Hirokazu Murakami; Shougo Shinonome; Hirohisa Saito; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 5.  Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Sofia Taddei; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Chronic Dis       Date:  2016-08-11       Impact factor: 5.091

6.  Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

Authors:  M Nitschke; K Sohn; D Dieckmann; B F Gibbs; H H Wolff; U Amon
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

7.  Glycomic analysis of human mast cells, eosinophils and basophils.

Authors:  Simon J North; Stephan von Gunten; Aristotelis Antonopoulos; Alana Trollope; Donald W MacGlashan; Jihye Jang-Lee; Anne Dell; Dean D Metcalfe; Arnold S Kirshenbaum; Bruce S Bochner; Stuart M Haslam
Journal:  Glycobiology       Date:  2011-07-01       Impact factor: 4.313

Review 8.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

Review 9.  Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Sofia Taddei; Luigi Zucchi
Journal:  J Asthma Allergy       Date:  2015-10-08

Review 10.  The clinical profile of benralizumab in the management of severe eosinophilic asthma.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Respir Dis       Date:  2016-09-09       Impact factor: 4.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.